EUCTR2007-002553-23-DE
Active, not recruiting
Not Applicable
Clinical trial to assess the protective effect of the fixed drug combination of disodium cromoglycate plus reproterol in comparison to the single components and placebo in adults with exercise induced asthma - AERIA
ConditionsExercise induced asthmaMedDRA version: 9.1Level: LLTClassification code 10015649Term: Exercise induced asthma
DrugsAllergospasmin N
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Exercise induced asthma
- Sponsor
- MEDA Pharma GmbH & Co. KG
- Status
- Active, not recruiting
- Last Updated
- 12 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Female and male subjects aged 18 – 65 years
- •2\.Exercise induced asthma with reversible airway obstruction: twice proven EIA defined as maximum decrease in FEV1 against the baseline value of at least 20% (first test results can be obtained during the last 12 months)
- •3\.Baseline FEV1 before challenge must be at least 70% of the predicted FEV1
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •Safety concerns:
- •1\.Subjects with hypersensitivity to DSCG, reproterol, menthol, peppermint or other excipients of the study medication
- •2\.Pregnancy, breast\-feeding or planned pregnancy during the study. Women of child bearing potential not using a highly effective method of birth control defined as those which results in a low failure rate (i.e. \< 1% per year) when used consistently and correctly such as implants, injectables, combined oral contraceptives, hormonal IUDs, tubal ligation or vasectomised partner.
- •3\. Subjects with an asthma exacerbation within 4 weeks prior to the study start. Asthma exacerbation defined as use of oral (systemic) glucocorticosteroids, unscheduled consultation of a medic due to asthma, hospitalisation, or additional treatment of asthma with antibiotics
- •4\. Eosinophilic pneumonia
- •5\. Clinically significant cardiovascular diseases (e.g. cardiac infarction, cardiac dysrhythmia, hypertrophic obstructive cardiomyopathy, coronary heart disease...)
- •6\. Resting blood pressure over 140/90 mmHg
- •7\. Diastolic blood pressure after treadmill\-test over 120 mmHg
- •8\. Malignancies including phaeochromocytoma within the last 5 years
- •9\. Severe hyperthyreosis, thyreotoxicosis, instable diabetes mellitus
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 1
A clinical trial of psilocybin-assisted psychotherapy for treatment-resistant anorexia nervosaAnorexia NervosaMental Health - Eating disordersACTRN12623000357651niversity of Sydney30
Completed
Not Applicable
Clinical trial to test the efficacy and safety of topical application of IP in management of pain associated with musclesHealth Condition 1: M959- Acquired deformity of musculoskeletal system, unspecifiedCTRI/2019/11/021874Vasu Healthcare Pvt Ltd114
Completed
Not Applicable
Clinical trial to evaluate efficacy and safety of low molecular collagen peptides for joint paiKCT0007584Yonsei University Health System, Severance Hospital78
Completed
Phase 3
Clinical trial to evaluate efficacy and safety of KCS03 stent in a native coronary lesioStable angina, unstable angina and non-ST elevated myocardial infarction with de novo or restenotic coronary lesionsJPRN-UMIN000010422Kaneka Corporation115
Completed
Phase 2
Clinical trial to evaluate efficacy and safety of cyclophosphamide, bortezomib and dexamethasone (CBD) induction and autologous stem cell transplantation for patients for newly diagnosed multiple myeloma (NBMT-ASCT1201)multiple myelomaJPRN-UMIN000008399Toyohashi Municipal Hospital Division of Hematology and Oncology54